The Pyrosequencing-Based Method for

Elena Pozdysheva, Tatiana Subbotina, Yana Voytsekhovskaya, Aleksandra Shalyova, Elena Martynova, Konstantin Mironov, Vasily Akimkin

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elena PozdyshevaCentral Research Institute of Epidemiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing of Russian Federation, 111123 Moscow, Russia.ORCID 0000-0002-4477-8506

Tatiana SubbotinaSchool of Fundamental Biology and Biotechnology, Siberian Federal University, 660041 Krasnoyarsk, Russia.

Yana VoytsekhovskayaCentral Research Institute of Epidemiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing of Russian Federation, 111123 Moscow, Russia.

Aleksandra ShalyovaSchool of Fundamental Biology and Biotechnology, Siberian Federal University, 660041 Krasnoyarsk, Russia.

Elena MartynovaRegional Clinical Hospital, 660022 Krasnoyarsk, Russia.

Konstantin MironovCentral Research Institute of Epidemiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing of Russian Federation, 111123 Moscow, Russia.ORCID 0000-0001-8207-9215

Vasily AkimkinCentral Research Institute of Epidemiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing of Russian Federation, 111123 Moscow, Russia.ORCID 0000-0003-4228-9044

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

JAK2 exon 12myeloproliferative diseasepolycythemia verapyrosequencing

Identifiers

PMID42351414

DOI10.3390/diagnostics16121754

PMCPMC13298268

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.